Gupta Suneel
Chief Development Officer at PTGX
- Sold, on record
- $5.8M
- Dollars the filings state
- Form 4 sales
- 2
- Latest Nov 26, 2024
- Form 144 notices
- 3
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- PTGXProtagonist Therapeutics, IncChief Development Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice PTGXNoticeJan 9, 2024 2024
Filed to sell 5,000 shares ($125k)
Gupta Suneel, Officer
10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale PTGXRoutineJan 9, 2024 same day
Sold 5,000 shares at $25.00 ($125k)
Gupta Suneel, Chief Development Officer
10b5-1 planSold 2.6% of holdings ($4.8M position)187,567 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 144 notice PTGXNoticeNov 25, 2024 +321 days
Filed to sell 103,437 shares ($4.8M)
Gupta Suneel, Officer
No 10b5-1 planFirst sale on recordFiling
- 4 Form 144 notice PTGXNoticeNov 26, 2024 +1 day
Filed to sell 19,191 shares ($873k)
Gupta Suneel, Officer
No 10b5-1 planFirst sale on recordFiling
- 5 Form 4 sale PTGXUnusualNov 26, 2024 same day
Sold 122,628 shares at $45.96 ($5.6M)
Gupta Suneel, Chief Development Officer
No 10b5-1 planSold 31.5% of holdings ($17.9M position)266,983 shares leftFirst sale on recordFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 26, 2024 | Nov 27, 2024 | PTGX | Chief Development Officer | Form 4 sale | 122,628 | $5.6M | 31.5% | Unusual | SEC |
| Nov 26, 2024 | Nov 26, 2024 | PTGX | Officer | Form 144 notice | 19,191 | $873k | Notice | SEC | |
| Nov 25, 2024 | Nov 25, 2024 | PTGX | Officer | Form 144 notice | 103,437 | $4.8M | Notice | SEC | |
| Jan 9, 2024 | Jan 11, 2024 | PTGX | Chief Development Officer | Form 4 sale | 5,000 | $125k | 2.6% | Routine | SEC |
| Jan 9, 2024 | Jan 9, 2024 | PTGX | Officer | Form 144 notice | 5,000 | $125k | Notice | SEC |